Physician profile
Wilson Cook
NPI 1326002775
$17,377.71
in general payments reported to CMS, 2019-2025
59 companies · $2,859 in 2025
The $2,859 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,385 · 2020: $1,634 · 2021: $2,551 · 2022: $2,794 · 2023: $2,538 · 2024: $2,616 · 2025: $2,859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,919 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,919.31 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,312.71 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $1,551.70 | 2019-2025 | |
| Novo Nordisk INC | $1,443.89 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,379.17 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $1,017.28 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $865.42 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $864.32 | 2019-2025 | Evenity, Repatha, Otezla |
| Astellas Pharma US INC | $726.76 | 2019-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $644.64 | 2019-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $604.60 | 2019-2025 | Jardiance |
| Abbott Laboratories | $416.98 | 2019-2025 | Freestyle Libre 3 |
| Allergan, INC. | $400.86 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $397.98 | 2019-2024 | |
| Esperion Therapeutics, INC. | $328.39 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $315.29 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $309.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $305.83 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $279.58 | 2020-2025 | Rexulti |
| Amarin Pharma, INC. | $246.34 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $229.74 | 2019-2025 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $228.58 | 2022 | |
| Lundbeck LLC | $211.30 | 2021-2025 | Rexulti |
| Sumitomo Pharma America, INC. | $186.43 | 2023-2025 | Gemtesa |
| Vanda Pharmaceuticals INC. | $161.37 | 2019-2023 | Hetlioz |
| Sunovion Pharmaceuticals INC. | $150.97 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $135.75 | 2021-2024 | Eliquis |
| Sanofi-Aventis U.S. LLC | $132.13 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $111.07 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $104.52 | 2019-2024 | Xarelto |
| Axsome Therapeutics, INC. | $93.58 | 2023-2025 | Auvelity, Sunosi |
| Inspire Medical Systems, INC. | $89.38 | 2023 | Inspire |
| Teva Pharmaceuticals USA, INC. | $88.73 | 2022-2023 | Ajovy, Austedo |
| Dexcom, INC. | $80.47 | 2021-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $76.76 | 2024 | Caplyta |
| Boston Scientific Corporation | $70.43 | 2023-2024 | Bodyguardian, Wavewriter Alpha Prime 16, Watchman Access System |
| Xeris Pharmaceuticals, INC. | $68.10 | 2022-2023 | Gvoke Hypopen |
| Horizon Therapeutics Plc | $55.85 | 2020 | |
| Daiichi Sankyo INC. | $55.03 | 2020-2024 | Injectafer |
| Mylan Specialty L.P. | $53.71 | 2019-2023 | Yupelri |
| Biohaven Pharmaceuticals, INC. | $50.18 | 2021 | |
| Sanofi Pasteur INC. | $47.71 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $42.73 | 2023-2025 | Opsumit, Uptravi |
| Eisai INC. | $41.16 | 2020-2021 | |
| Clarus Therapeutics INC. | $41.03 | 2021 | |
| Philips North America LLC | $37.62 | 2024 | (Ck6) Holter |
| Dynavax Technologies Corporation | $32.94 | 2024 | Heplisav-B |
| Genentech USA, INC. | $32.08 | 2019-2020 | |
| Alk-Abello, INC | $30.56 | 2025 | Odactra, Ragwitek, Grastek |
| Ultragenyx Pharmaceutical INC. | $28.72 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $27.68 | 2024 | Unithroid |
| Medtronic USA, INC. | $26.88 | 2019-2020 | |
| Medtronic, INC. | $24.78 | 2021-2023 | Inpen Smart Insulin Delivery System |
| Supernus Pharmaceuticals, INC. | $22.90 | 2019 | |
| Baxter Healthcare | $19.99 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Seqirus USA INC | $16.60 | 2019 | |
| Edwards Lifesciences Corporation | $16.25 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Tolmar, INC. | $15.31 | 2024 | |
| Ironwood Pharmaceuticals, INC | $13.69 | 2019 | |
| Ardelyx, INC. | $13.65 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.